7:27AM On The Wires (WIRES) : Dyax Corp. (DYAX) and Eclipse Therapeutics announced that Dyax has granted Eclipse an exclusive worldwide license for the development and commercialization of preclinical fully-human antibodies discovered using Dyax's gold-standard phage display technology for use in oncology indications.